Abstract “Platinum resistant” ovarian cancer was historically defined as disease recurrence
within 6 months of completion of first-line platinum-based chemotherapy, although this is …

Background Serum CA125 concentration often rises several months before clinical or
symptomatic relapse in women with ovarian cancer. In the MRC OV05/EORTC 55955 …

Ovarian and endometrial cancer will be diagnosed in over 63,000 women in 2009, resulting
in 22,000 deaths in the USA. Histologic screening, such as pap smears for detection of …

Background While the underlying causes of cancer are genetic modifications, changes in
cellular states mediate cancer development. Tumor cells display markedly changed …

Background The absence of highly sensitive and specific serum biomarkers makes mass
screening for ovarian cancer impossible. The claudin proteins are frequently overexpressed …

This review article summarizes the role of PET/CT and PET/MRI in ovarian cancer. With
regard to the diagnosis of ovarian cancer, the presence of FDG uptake within the ovary of a …

Objective To evaluate whether human epididymis protein 4 (HE 4) and CA 125 correlate
with known high‐risk prognostic factors for endometrial cancer. Design Prospective …

Background Elucidation of the repertoire of secreted and cell surface proteins of tumor cells
is relevant to molecular diagnostics, tumor imaging and targeted therapies. We have …

Knowledge of mucins and their multiple roles in various normal and pathological processes
has improved greatly in the past two decades. Mucins belong to a family of glycoproteins …

COVID-19 crisis affects ovarium cancer patients seriously. Thus, it is vital to diagnose
ovarium cancer, one of the most common types of cancer diagnosed and the causes of …